EARLY CLINICAL EXPERIENCE WITH PIRFENIDONE FOR IDIOPATHIC PULMONARY FIBROSIS (IPF) IN THE UK: INTERIM RESULTS FROM A UK COHORT

被引：2
|
作者：
Parfrey, H. [1 ]
Leonard, C. [2 ]
Gibbons, M. A. [3 ]
Harris, E. [1 ]
Frank, R. [2 ]
Sharp, C. [3 ]
Dew, R. M. [4 ]
Maher, T. M. [5 ]
机构：
[1] Papworth Hosp NHS Fdn Trust, Cambridge, England
[2] Univ Hosp Manchester NHS Fdn Trust, Manchester, Lancs, England
[3] Royal Devon & Exeter NHS Fdn Trust, Exeter, Devon, England
[4] pH Associates Ltd, Marlow, Bucks, England
[5] Royal Brompton & Harefield NHS Fdn Trust, London, England
来源：
THORAX | 2012年 / 67卷
关键词：
D O I：
10.1136/thoraxjnl-2012-202678.103
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：A48 / A49
页数：5
相关论文
共 50 条
  • [1] EXTENDED CLINICAL EXPERIENCE WITH PIRFENIDONE DURING A NAMED PATIENT PROGRAMME FOR IDIOPATHIC PULMONARY FIBROSIS (IPF): INTERIM RESULTS
    Partfrey, H.
    Chaudhuri, N.
    Gibbons, M. A.
    Anning, L.
    Balkin, M.
    Cooper, S.
    Dew, R.
    Maher, T. M.
    THORAX, 2014, 69 : A196 - A196
  • [2] Pirfenidone in idiopathic pulmonary fibrosis (IPF): Early single centre Irish experience
    Barry, Peter
    Murphy, Lorna
    Tuohy, Majella
    Judge, Eoin
    Egan, Jim
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [3] NINTEDANIB FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS - INITIAL CLINICAL EXPERIENCE IN A UK COHORT
    Fletcher, S. V.
    Jones, M. G.
    Renzoni, E.
    Parfrey, H.
    Hoyles, R.
    Spinks, K.
    Kokosi, M.
    Kwok, A.
    Warburton, C.
    Titmuss, V.
    Maher, T.
    Chua, F.
    Wells, A.
    Richeldi, L.
    Spencer, L. G.
    THORAX, 2015, 70 : A78 - A78
  • [4] Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis
    Bonella, Francesco
    Wessendorf, Thomas
    Costabel, Ulrich
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [5] Pirfenidone in idiopathic pulmonary fibrosis (IPF): Early Spanish experience with the European Named patient program (NPP)
    Nieto Barbero, Ma Asuncion
    Valenzuela, Claudia
    Rivera Ortega, Pilar
    Zulueta Frances, Javier
    Signes-Costa, Jaime
    Marin, Manuela
    Martin, Irene
    Hernandez, Fernanda
    Garcia-Sevilla, Raquel
    Casanova, Alvaro
    Portillo, Karina
    Herrera, Susana
    Antonio Rodriguez-Portal, Jose
    Romero, Ana
    Balcells, Eva
    Angel Figuerola, Jose
    Laparra, Javier
    Martinez, Cristina
    Moreno, Amalia
    Zabaleta, Miguel
    Bollo, Elena
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [6] Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis
    Bonella, F.
    Wessendorf, T. E.
    Costabel, U.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (11) : 518 - 523
  • [7] Safety Of The Combined Use Of Pirfenidone And Nintedanib In Patients With Idiopathic Pulmonary Fibrosis (ipf): Results From An Interim Analysis After 12 Weeks
    Flaherty, K. R.
    Sussman, R.
    Pesci, A.
    Nunes, H.
    Acosta, O.
    Petzinger, U.
    Stauffer, J.
    Gilberg, F.
    Bengus, M.
    Lancaster, L. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [8] IPF Care, a support program for patients with idiopathic pulmonary fibrosis in the UK
    Duck, Annette
    Pigram, Lucy
    Ahmed, Deeba
    Chaudhuri, Nazia
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [9] Pirfenidone For Idiopathic Pulmonary Fibrosis: Results Of A Nationwide Danish Experience
    Salih, G. N.
    Shaker, S. B.
    Madsen, H. D.
    Bendstrup, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [10] Prescription Of Pirfenidone And Nintedanib For The Treatment Of Idiopathic Pulmonary Fibrosis (ipf): An Academic Center Experience
    Strock, S.
    Nouraie, S. M.
    Huttenhower, D.
    Chen, X.
    Lawson, K.
    Priore, M. Melissa
    Chiarchiaro, J.
    Veraldi, K. L.
    Lindell, K. O.
    Gibson, K. F.
    Kass, D. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
12345